Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2008

Open Access 01-12-2008 | Research article

Validation of putative reference genes for gene expression studies in human hepatocellular carcinoma using real-time quantitative RT-PCR

Authors: Vito R Cicinnati, Qingli Shen, Georgios C Sotiropoulos, Arnold Radtke, Guido Gerken, Susanne Beckebaum

Published in: BMC Cancer | Issue 1/2008

Login to get access

Abstract

Background

Reference genes, which are often referred to as housekeeping genes are frequently used to normalize mRNA levels between different samples in quantitative reverse transcription polymerase chain reaction (qRT-PCR). The selection of reference genes is critical for gene expression studies because the expression of these genes may vary among tissues or cells and may change under certain circumstances. Here, a systematic evaluation of six putative reference genes for gene expression studies in human hepatocellular carcinoma (HCC) is presented.

Methods

Six genes, beta-2-microglobulin (B2M), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), hydroxymethyl-bilane synthase (HMBS), hypoxanthine phosphoribosyl-transferase 1 (HPRT1), succinate dehydrogenase complex, subunit A (SDHA) and ubiquitin C (UBC), with distinct functional characteristics and expression patterns were evaluated by qRT-PCR. Inhibitory substances in RNA samples were quantitatively assessed and controlled using an external RNA control. The stability of selected reference genes was analyzed using both geNorm and NormFinder software.

Results

HMBS and GAPDH were identified as the optimal reference genes for normalizing gene expression data between paired tumoral and adjacent non-tumoral tissues derived from patients with HCC. HMBS, GAPDH and UBC were identified to be suitable for the normalization of gene expression data among tumor tissues; whereas the combination of HMBS, B2M, SDHA and GAPDH was suitable for normalizing gene expression data among five liver cancer cell lines, namely Hep3B, HepG2, HuH7, SK-HEP-1 and SNU-182. The determined gene stability was increased after exclusion of RNA samples containing relatively higher inhibitory substances.

Conclusion

Of six genes studied, HMBS was found to be the single best reference gene for gene expression studies in HCC. The appropriate choice of combination of more than one reference gene to improve qRT-PCR accuracy depends on the kind of liver tissues or cells under investigation. Quantitative assessment and control of qRT-PCR inhibitors using an external RNA control can reduce the variation of qRT-PCR assay and facilitate the evaluation of gene stability. Our results may facilitate the choice of reference genes for expression studies in HCC.
Appendix
Available only for authorised users
Literature
1.
Vandesompele J, De PK, Pattyn F, Poppe B, Van RN, De PA, et al: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3: RESEARCH0034-10.1186/gb-2002-3-7-research0034.CrossRefPubMedPubMedCentral
2.
Ginzinger DG: Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol. 2002, 30: 503-512. 10.1016/S0301-472X(02)00806-8.CrossRefPubMed
3.
Huggett J, Dheda K, Bustin S, Zumla A: Real-time RT-PCR normalisation; strategies and considerations. Genes Immun. 2005, 6: 279-284. 10.1038/sj.gene.6364190.CrossRefPubMed
4.
Dheda K, Huggett JF, Bustin SA, Johnson MA, Rook G, Zumla A: Validation of housekeeping genes for normalizing RNA expression in real-time PCR. BioTechniques. 2004, 37: 112-119.PubMed
5.
Dheda K, Huggett JF, Chang JS, Kim LU, Bustin SA, Johnson MA, et al: The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization. Anal Biochem. 2005, 344: 141-143. 10.1016/j.ab.2005.05.022.CrossRefPubMed
6.
Valenti MT, Bertoldo F, Dalle CL, Azzarello G, Zenari S, Zanatta M, et al: The effect of bisphosphonates on gene expression: GAPDH as a housekeeping or a new target gene?. BMC Cancer. 2006, 6: 49-10.1186/1471-2407-6-49.CrossRefPubMedPubMedCentral
7.
Selvey S, Thompson EW, Matthaei K, Lea RA, Irving MG, Griffiths LR: Beta-actin – an unsuitable internal control for RT-PCR. Mol Cell Probes. 2001, 15: 307-311. 10.1006/mcpr.2001.0376.CrossRefPubMed
8.
Arukwe A: Toxicological housekeeping genes: do they really keep the house?. Environ Sci Technol. 2006, 40: 7944-7949. 10.1021/es0615223.CrossRefPubMed
9.
Tricarico C, Pinzani P, Bianchi S, Paglierani M, Distante V, Pazzagli M, et al: Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Anal Biochem. 2002, 309: 293-300. 10.1016/S0003-2697(02)00311-1.CrossRefPubMed
10.
Thellin O, Zorzi W, Lakaye B, De BB, Coumans B, Hennen G, et al: Housekeeping genes as internal standards: use and limits. J Biotechnol. 1999, 75: 291-295. 10.1016/S0168-1656(99)00163-7.CrossRefPubMed
11.
Tanic N, Perovic M, Mladenovic A, Ruzdijic S, Kanazir S: Effects of aging, dietary restriction and glucocorticoid treatment on housekeeping gene expression in rat cortex and hippocampus-evaluation by real time RT-PCR. J Mol Neurosci. 2007, 32: 38-46. 10.1007/s12031-007-0006-7.CrossRefPubMed
12.
13.
Parkin DM, Pisani P, Ferlay J: Global cancer statistics. CA Cancer J Clin. 1999, 49: 33-64. 10.3322/canjclin.49.1.33.CrossRefPubMed
14.
Fang H, Tong W, Perkins R, Shi L, Hong H, Cao X, et al: Bioinformatics approaches for cross-species liver cancer analysis based on microarray gene expression profiling. BMC Bioinformatics. 2005, 6 (Suppl 2): S6-10.1186/1471-2105-6-S2-S6.CrossRefPubMedPubMedCentral
15.
Segal E, Sirlin CB, Ooi C, Adler AS, Gollub J, Chen X, et al: Decoding global gene expression programs in liver cancer by noninvasive imaging. Nat Biotechnol. 2007, 25: 675-680. 10.1038/nbt1306.CrossRefPubMed
16.
Li B, Perabekam S, Liu G, Yin M, Song S, Larson A: Experimental and bioinformatics comparison of gene expression between T cells from TIL of liver cancer and T cells from UniGene. J Gastroenterol. 2002, 37: 275-282. 10.1007/s005350200035.CrossRefPubMed
17.
Wakabayashi K, Saito H, Kaneko F, Nakamoto N, Tada S, Hibi T: Gene expression associated with the decrease in malignant phenotype of human liver cancer cells following stimulation with a histone deacetylase inhibitor. Int J Oncol. 2005, 26: 233-239.PubMed
18.
Kim JW, Wang XW: Gene expression profiling of preneoplastic liver disease and liver cancer: a new era for improved early detection and treatment of these deadly diseases?. Carcinogenesis. 2003, 24: 363-369. 10.1093/carcin/24.3.363.CrossRefPubMed
19.
Choi JK, Choi JY, Kim DG, Choi DW, Kim BY, Lee KH, et al: Integrative analysis of multiple gene expression profiles applied to liver cancer study. FEBS Lett. 2004, 565: 93-100. 10.1016/j.febslet.2004.05.087.CrossRefPubMed
20.
Chenivesse X, Franco D, Brechot C: MDR1 (multidrug resistance) gene expression in human primary liver cancer and cirrhosis. J Hepatol. 1993, 18: 168-172. 10.1016/S0168-8278(05)80243-0.CrossRefPubMed
21.
Pattyn F, Robbrecht P, De PA, Speleman F, Vandesompele J: RTPrimerDB: the real-time PCR primer and probe database, major update 2006. Nucleic Acids Res. 2006, 34: D684-D688. 10.1093/nar/gkj155.CrossRefPubMed
22.
Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, et al: The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol. 2006, 7: 3-10.1186/1471-2199-7-3.CrossRefPubMedPubMedCentral
23.
Arezi B, Salehi M: High-quality external RNA control detects inhibitors in RNA samples. Strategies. 2007, 19: 52-53.
24.
Warner JR: The economics of ribosome biosynthesis in yeast. Trends Biochem Sci. 1999, 24: 437-440. 10.1016/S0968-0004(99)01460-7.CrossRefPubMed
25.
Solanas M, Moral R, Escrich E: Unsuitability of using ribosomal RNA as loading control for Northern blot analyses related to the imbalance between messenger and ribosomal RNA content in rat mammary tumors. Anal Biochem. 2001, 288: 99-102. 10.1006/abio.2000.4889.CrossRefPubMed
26.
Spanakis E: Problems related to the interpretation of autoradiographic data on gene expression using common constitutive transcripts as controls. Nucleic Acids Res. 1993, 21: 3809-3819. 10.1093/nar/21.16.3809.CrossRefPubMedPubMedCentral
27.
Johnson ML, Redmer DA, Reynolds LP: Quantification of lane-to-lane loading of poly(A) RNA using a biotinylated oligo(dT) probe and chemiluminescent detection. BioTechniques. 1995, 19: 712-715.PubMed
28.
29.
Fleige S, Pfaffl MW: RNA integrity and the effect on the real-time qRT-PCR performance. Mol Aspects Med. 2006, 27: 126-139. 10.1016/j.mam.2005.12.003.CrossRefPubMed
30.
Kim CH, Khan M, Morin DE, Hurley WL, Tripathy DN, Kehrli M, et al: Optimization of the PCR for detection of Staphylococcus aureus nuc gene in bovine milk. J Dairy Sci. 2001, 84: 74-83.CrossRefPubMed
31.
Bessetti J: An Introduction to PCR Inhibitors. Profiles in DNA. 2007, 9-10.
32.
Freeman WM, Walker SJ, Vrana KE: Quantitative RT-PCR: pitfalls and potential. BioTechniques. 1999, 26: 112-115.PubMed
33.
Andersen CL, Jensen JL, Orntoft TF: Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004, 64: 5245-5250. 10.1158/0008-5472.CAN-04-0496.CrossRefPubMed
34.
Thorgeirsson SS, Grisham JW: Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 2002, 31: 339-346. 10.1038/ng0802-339.CrossRefPubMed
35.
Kim S, Kim T: Selection of optimal internal controls for gene expression profiling of liver disease. BioTechniques. 2003, 35: 456-460.PubMed
Metadata
Title
Validation of putative reference genes for gene expression studies in human hepatocellular carcinoma using real-time quantitative RT-PCR
Authors
Vito R Cicinnati
Qingli Shen
Georgios C Sotiropoulos
Arnold Radtke
Guido Gerken
Susanne Beckebaum
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2008
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-8-350

Other articles of this Issue 1/2008

BMC Cancer 1/2008 Go to the issue

Research article

Is the Satisfaction with Cancer Information Profile (SCIP) valid for tailoring information for patients with head and neck cancer?

Research article

Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients

Research article

Tumor necrosis is associated with increased alphavbeta3integrin expression and poor prognosis in nodular cutaneous melanomas

Research article

The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells

Research article

Cancer incidence in men: a cluster analysis of spatial patterns

Research article

Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits